Related Experiment Video
Updated: Aug 12, 2025

Isolation and Transplantation of Hematopoietic Stem Cells HSCs
Published on: February 25, 2007
Standardization and Accreditation in Haemopoietic Stem Cell Transplantation - an Asia Pacific Perspective
Sharat Damodar1, David D Ma2,3, Scott J Ragg4
1Dept of Haematology and BMT, Mazumdar shaw medical center, Narayana health city, India.
This article discusses how to improve the quality of hematopoietic stem cell transplantation (HSCT) in the Asia Pacific region. It emphasizes the importance of accurate CD34 cell counting and the role of accreditation in ensuring safe and effective treatments. The authors highlight the challenges faced by low- and middle-income countries in meeting international standards. They propose a staged approach to accreditation that allows these countries to gradually adopt best practices. The study uses data from the APBMT registry to support its recommendations. It concludes that quality assurance should be seen as an ongoing process, not a one-time achievement. The goal is to help more patients receive safe and successful HSCT treatments.
Area of Science:
- Hematopoietic stem cell transplantation
- Clinical laboratory standards
Background:
Accurate and standardized practices in hematopoietic stem cell transplantation are essential for ensuring consistent clinical outcomes. Prior research has shown that variability in laboratory procedures can affect patient safety and treatment success. However, many centers struggle to implement uniform standards, especially in low- and middle-income countries. This gap motivated the need for a structured approach to standardization and accreditation. The absence of a clear framework for quality assurance in HSCT remains a challenge in many regions. International accreditation models, while effective, may not be easily adaptable to local contexts. This uncertainty drove the development of region-specific strategies for quality improvement. Understanding how to balance global standards with local resources is crucial for expanding access to safe HSCT.
Purpose Of The Study:
This article aims to explore the role of standardization and accreditation in hematopoietic stem cell transplantation from an Asia Pacific perspective. It addresses the challenges of implementing international standards in diverse healthcare settings. The study focuses on three key areas: CD34 cell enumeration, accreditation experiences, and staged standardization in low- and middle-income countries. It seeks to provide insights into how quality assurance can be improved in HSCT practices. The authors highlight the need for a tailored approach to accreditation that considers local limitations. They emphasize the importance of continuous improvement rather than viewing accreditation as a one-time achievement. The goal is to support centers in developing sustainable quality systems. This approach may help reduce disparities in HSCT outcomes across the region.
Main Methods:
The study draws on experiences from Singapore General Hospital to illustrate the accreditation process under FACT-JACIE standards. It evaluates the role of external quality assurance programs in CD34 cell enumeration. Data from the Asia Pacific Bone Marrow Transplant registry are used to assess the current state of HSCT in the region. The authors analyze how accreditation requirements affect centers in low- and middle-income countries. They propose a staged model for implementing international standards in these settings. The study integrates qualitative insights from healthcare professionals involved in HSCT. It examines the challenges of resource allocation and training in quality assurance. The approach combines literature review with real-world examples to support its conclusions.
Main Results:
Accurate CD34 enumeration is critical for successful hematopoietic stem cell transplantation. The study found that external quality assurance programs significantly improve measurement accuracy. Singapore General Hospital's experience shows that accreditation is a continuous process, not a final goal. Many low- and middle-income countries struggle to meet international accreditation requirements. The data from the APBMT registry reveal disparities in HSCT practices across the Asia Pacific region. A staged approach to accreditation is proposed to address these challenges. This model allows centers to gradually adopt international standards while maintaining quality. The study highlights the importance of adapting global frameworks to local contexts.
Conclusions:
The authors suggest that standardization and accreditation are key to improving HSCT outcomes in the Asia Pacific region. They emphasize the need for a flexible approach to accreditation that considers local resources. The study supports the use of external quality assurance programs for CD34 cell enumeration. It concludes that accreditation should be viewed as a continuous improvement process. The data from the APBMT registry indicate a need for greater regional collaboration. The authors propose a staged model for accreditation in low- and middle-income countries. This approach may help reduce disparities in HSCT quality. The study highlights the importance of adapting global standards to local needs.
Frequently Asked Questions
CD34 enumeration is critical for determining the viability and quantity of stem cells used in HSCT. Accurate counts help ensure successful engraftment and reduce transplant complications.
FACT-JACIE accreditation promotes quality assurance in HSCT by setting international standards for laboratory and clinical practices. It supports continuous improvement in patient care.
A staged approach allows centers in low- and middle-income countries to gradually adopt international standards. It helps manage resource limitations while maintaining quality in HSCT.
External quality assurance programs improve the accuracy of CD34 cell counts. They help standardize laboratory practices and reduce variability across HSCT centers.
The APBMT registry provides data on HSCT practices across the Asia Pacific region. It helps identify disparities and supports the development of region-specific quality strategies.
The authors recommend a staged model for accreditation that adapts international standards to local contexts. This approach supports continuous quality improvement in HSCT.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Lineage Commitment
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Multipotency of Hematopoietic Stem Cells

